The Functional Genomics Core (FGC) will provide reagents, strategic, and technical expertise required for efficient investigation of genetic variants likely to be mechanistically important in pediatric rheumatic and inflammatory diseases. In doing so, the FGC will enhance research productivity and efficiency by effectively reducing the ?start-up? time required to implement these complex experimental systems, thus reducing costs and effort required and allowing for better study designs and higher quality studies than if investigators were to individually establish this technology. Further, this core will provide access to state-of-the-art technology without requiring the users to become experts in these technologies. The FGC core will be a practical vehicle for the translation of basic advances to clinical disease applications and their very important insights in to pathogenesis. We will specifically provide consultation, collaboration, hands-on technical expertise and starter reagents to the research community to identify the biological function of genetic variants (Aim1) and apply genomic editing technology (Aim 2) to assess the biological function of genetic variants associated with of autoimmune, autoinflammatory, and immune-related rheumatic pediatric diseases. We expect the FGC to be a hub of innovation for the research community, connecting scientists with the tools and expertise to take their research projects to the next level and to accelerate the discovery of the molecular mechanisms that are responsible for the genetic associations observed.

National Institute of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZAR1-YL (M1))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Cincinnati Children's Hospital Medical Center
United States
Zip Code
Patterson, Andrew R; Endale, Mehari; Lampe, Kristin et al. (2018) Gimap5-dependent inactivation of GSK3? is required for CD4+ T cell homeostasis and prevention of immune pathology. Nat Commun 9:430
Hinks, Anne; Marion, Miranda C; Cobb, Joanna et al. (2018) Brief Report: The Genetic Profile of Rheumatoid Factor-Positive Polyarticular Juvenile Idiopathic Arthritis Resembles That of Adult Rheumatoid Arthritis. Arthritis Rheumatol 70:957-962
Patel, Zubin; Lu, Xiaoming; Miller, Daniel et al. (2018) A plausibly causal functional lupus-associated risk variant in the STAT1-STAT4 locus. Hum Mol Genet :
Sherrill, Joseph D; Kc, Kiran; Wang, Xinjian et al. (2018) Whole-exome sequencing uncovers oxidoreductases DHTKD1 and OGDHL as linkers between mitochondrial dysfunction and eosinophilic esophagitis. JCI Insight 3:
Gohar, Faekah; Anink, Janneke; Moncrieffe, Halima et al. (2018) S100A12 Is Associated with Response to Therapy in Juvenile Idiopathic Arthritis. J Rheumatol 45:547-554
Nigrovic, Peter A; Raychaudhuri, Soumya; Thompson, Susan D (2018) Review: Genetics and the Classification of Arthritis in Adults and Children. Arthritis Rheumatol 70:7-17
Brunner, Hermine I; Holland, Michael; Beresford, Michael W et al. (2018) American College of Rheumatology Provisional Criteria for Global Flares in Childhood-Onset Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken) 70:813-822
Ohl, Kim; Nickel, Helge; Moncrieffe, Halima et al. (2018) The transcription factor CREM drives an inflammatory phenotype of T cells in oligoarticular juvenile idiopathic arthritis. Pediatr Rheumatol Online J 16:39
Rydyznski, Carolyn E; Cranert, Stacey A; Zhou, Julian Q et al. (2018) Affinity Maturation Is Impaired by Natural Killer Cell Suppression of Germinal Centers. Cell Rep 24:3367-3373.e4
Harley, John B; Chen, Xiaoting; Pujato, Mario et al. (2018) Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity. Nat Genet 50:699-707

Showing the most recent 10 out of 68 publications